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Background: Setting priorities in oncology is a useful way to produce a robust set of
research questions that researchers can address.Objective: The aim of this review was to
describe cancer nurses and patients' main research priorities and describe their development
over time.Methods:Amixed-method systematic reviewwas conducted for the period from
2000 to 2018 through a search of multiple databases. The methodological quality of the
studies included was assessed using the Mixed-Methods Appraisal Tool, and the process of
setting the health research priorities was assessed using Viergever's tool. Each study's top
research priorities were extracted and summarized in categories. Results: Fifteen studies
were included: 13 addressed nurses' research priorities, and 2 focused on those of patients.
The majority were Delphi and quantitative studies that were conducted in the United States
and United Kingdom. The quality criteria score and the quality of the process were
considered sufficiently good. The most important research priorities were categorized as
disease control and management, patient-related issues, and professional dimensions and
issues. Management of symptoms and pain, education, information, and communication
were research priorities always present in the articles during the study period.Conclusion:
Priorities change over time and depend on several factors; however, some have remained
consistent for the last 18 years. Although there is increasing emphasis on including patients
in establishing research priorities that inform cancer care, this involvement is still lacking.
Implications for Practice: Future studies should describe the primary cancer research
priorities of nurses in collaboration with patients.
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Cancer care is changing constantly and is increasingly com-plex because of advances in science, technology, and treat-ments.1,2 These advances, including such new therapies as
targeted agents and immunotherapies that require a personalized ap-
proach to care, have increased the survival of patients with cancer.3
Such improvements have been made across cancer services, from
better prevention and screening (eg, home tests for colorectal cancer)
to new forms of surgery (eg, robotic surgical systems) and enhanced
recovery and survivorship programs.1 These changes also concern
patients' health behaviors, clinicians' decisions, medical delivery sys-
tems, and symptommanagement4 and increasingly require a multi-
disciplinary approach to cancer care.5
To compound this increasing complexity, the number of
patients with cancer also is increasing rapidly.6 In 2018, almost
18.1 million new cancer cases were estimated and 9.6 million
cancer deaths occurred worldwide compared with 14.1 million
new cancer cases and 8.2 million cancer deaths in 2012.6,7
Cancer nurses struggle to meet the challenges of providing
quality nursing care in this changing environment. To help them
keep pace and develop new competencies necessary, nursing re-
search priorities should be established.2,8 While prevention and
treatment modalities are being developed in clinical research,
nursing research should focus on the people involved directly
(patients and families) to understand the new care needs or the
effects of the care practiced.8 Efforts, therefore, should focus not
only on improving cancer care quality9 but also on implementing
best clinical practices with the goal to improve patient outcomes.10
Outlining priorities also can help focus on a particular issue rather
than promoting isolated and unrelated studies of patients' needs.
There also is a practical reason to do so, in that there are limited
resources available for nursing research.2,11
Promoting healthcare services users' involvement in making
healthcare decisions has attracted increasing attention. Such involve-
ment has expanded from the clinical practice to the research setting
to bridge any gaps between the answers that patients seek and those
that research provides.12–14 Considering the patients' point of view
makes research relevant and valuable for them and their caregivers
and thus changes the traditional clinician-patient relationship.13
This approach has led to studies that include the patients' point
of view in setting research priorities. For example, Jones and
colleagues12 identified patients, caregivers, and clinicians' top
10 kidney cancer research priorities.
Although the many innovations and rapid developments in
research have brought about major changes in cancer care, it is
unclear whether the research priorities related to nurses and pa-
tients reflect these changes over time.
The aims of this mixed-method systematic review were to de-
scribe primary cancer research priorities based on the perspective
of oncology nurses, patients with cancer, and other users of on-
cology services and to report their development over time.
n Methods
Amixed-method systematic review was performed in 2017/2018
according to the Joanna Briggs Institute Reviewers' Manual15 and
reported following the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses guidelines.16 This type of review
integrates qualitative and quantitative research (research ques-
tions, methods, techniques for collecting/analyzing data, and
the findings are of both qualitative and quantitative type),
as well as mixed-methods studies, in order not to neglect any
important evidence.17
The study protocol was registered at PROSPERO, the inter-
national prospective register of systematic reviews (registration
number: CRD42017059721).
Eligibility Criteria and Search
The review question was defined with respect to a modified version
of PICO (population, interventions, comparison, outcomes16,18),
in which “intervention” and “comparison” were replaced by “phe-
nomenon of interest.” An iterative interrogative process was
followed to develop the search terms for the review questions
using the following definitions:
1. Population: Patients diagnosed with cancer (oncology patient,
oncology user, healthcare user, cancer patient, cancer con-
sumer, survivor) or nurses assisting patients with cancer in
an oncology ward.
2. Phenomenon of interest: Issue, patients’ perspective, needs and
needs unmet, demand, health service needs, unresolved prob-
lems, research priorities, cancer priorities, and health priorities.
3. Outcomes: “Nursing research priorities” or “patient research
priorities.”
Studies' inclusion criteria were that they (1) investigated
oncology nurses or patients' research priorities; (2) used a quan-
titative, qualitative, or mixed-method research design; (3) were
published in English; (4) had abstracts readily available; (5) had
an adult population (≥18 years old); and (6) were published be-
tween 2000 and 2018. Studies' exclusion criteria were if they (1)
did not report or discuss explicitly nurses or patients' research
priorities or needs identified as research priorities; (2) included
children, adolescents, or older patients; (3) focused on the palli-
ative care setting; (4) involved patients with hematological cancer
or those undergoing bone marrow transplantation because behav-
iors, treatments, and outcomes are different from solid tumors19;
or (5) investigated caregivers. Furthermore, studies were excluded
if they reported only nurses' perceptions of patients' priorities, or
the converse. Finally, in addition, systematic reviews were excluded,
although their reference lists were examined.
A systematic search of the literature was conducted with the
following electronic databases: MEDLINE, CINAHL, Scopus,
Psychology and Behavioral Sciences Collection, the Cochrane
Database of Systematic Reviews, TDNet, and PROSPERO. Initial
electronic searches were run between January 15 and March 31,
2017, and updated on November 30, 2018. This electronic re-
search was accompanied by manual research in nursing journals.
Medical SubjectHeadings and key terms were exploded where
possible and modified as necessary for the various databases
(Appendix 1). The main key terms were “cancer nursing,” “oncology
patient,” “research priorities,” and “cancer priorities.” Searching cita-
tions and checking reference lists and gray literature (Gray Literature
database in the Cancer Institute's website, Oncology Nursing
Societies website, The Grey Literature Report) were used only to
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identify additional articles for inclusion. All records identified were
inserted into EndNote (X7.8), and any duplicates were deleted.
Data Collection Process
Two reviewers selected the studies independently according to
their titles, keywords, and abstracts and then read the full texts
of the articles selected. Discrepancies in the selection process were
resolved in a consensus meeting with a third researcher. Interrater
agreement on the inclusion of studies was calculated using the
weighted κ statistic with κ < 0 indicating poor agreement,
κ = 0-0.20 indicating slight agreement, κ = 0.21-0.40 indicating
fair agreement, κ = 0.41-0.60 indicating moderate agreement,
κ = 0.61-0.80 indicating substantial agreement, and κ = 0.81-
1.00 indicating nearly perfect agreement.20
The details of each study included were noted according to
the Institute of Medicine's21 (2011) criteria: goal and study
design, research priority identified, methodology, sample and
setting, and findings and conclusions. At the end of each phase
of the review process, the number of studies excluded and the
reasons for their exclusion were recorded.
n Appraisal
Two different evaluation approaches were used in this review.
The methodological quality of studies included was assessed
using the Mixed-Methods Appraisal Tool (MMAT).22 This tool
was chosen because it can evaluate the primary studies'methodology—
quantitative, qualitative, andmixed-method/combined. TheMMAT's
validity and reliability have been documented previously.23–25 The
tool poses 2 questions for screening purposes and 4 questions about
methodological quality that differ for qualitative and quantitative
study designs. There are 3 possible answers to each question (“yes,”
“no,” or “can't tell”). For the 4 questions about methodological
quality, every “yes” (star) is converted to a percentage that is summed
for a total score that ranges from 1 (25%) to 4 (100%) stars.22
The process of setting the health research priority was evalu-
ated using the principles of good practice proposed by Viergever
and colleagues.26 Their checklist encompasses 9 common themes
to prioritize the research process grouped into 3 categories: (1)
preparatory work (context [7 items], use of a comprehensive ap-
proach [1 item], inclusiveness [5 items], information gathering [1
item], and planning for implementation [1 item]), (2) deciding
on priorities (criteria [1 item] andmethods for deciding on priorities
[1 item]), and (3) after priorities have been set (evaluation [1 item]
and transparency [1 item]). There are 2 possible answers to each
item (“yes” or “no”). A total of 20 aspects of the process of setting
health research priorities were assessed.
Two reviewers assessed the methods and process quality of
the studies included independently, and discrepancies were resolved
through discussion between these 2 and other reviewers.
n Synthesis of Study Findings
First, the 2 researchers collected information about the following
variables: research priorities (outcomes), description, and references.
Then, content analysis was performed to identify the most
frequent outcomes, as Vaismoradi et al27 described. This method
was chosen because it is suitable for summarizing assorted data.
The outcomes were classified into categories, which were developed
by regrouping similar characteristics and differences to establish
the narrative summary of the research priority.
Specifically, the units of analysis were the top research priorities
extracted, condensed, organized, and combined into categories. The
2 researchers (L.C., an oncology nurse, and V.B., a clinical nurse),
who were familiar with the data in their entirety, made the initial
codification, but the categories were refined in discussions and finally
confirmed by the entire research group. In addition, the 2 researchers
checked that all of the information relevant to the research questions
was included and fit in the final categories.
n Results
After an initial screening of 1596 records, 66 potentially eligible
articles were retained and their full text was retrieved. Of these,
48 were excluded (Figure 1), whereas 15 studies that met our
eligibility criteria were included.1–4,8,28–37 Interrater agreement
to include the studies was 0.70 (SE = 0.87, P < .001), indicating
strong agreement between the reviewers.
Study Characteristics
Among the 15 studies identified for this review (Table 1), 12
addressed nurses' research priorities,2–4,8,28,29,31–37 2 focused
on patients' research priorities,30,33 and 1 addressed nursing re-
search priorities from both nurses' and patients' perspectives.1 For
this last study, we considered only the data on the nurses' point of
view, because the patients reported only what they believed nurses'
research priorities were, without expressing their own priorities.
Nearly all articles were descriptive or Delphi studies that used
a quantitative or qualitative approach: 9 were descriptive, 5 were
Delphi (multistaged survey), and 1 was an exploratory qualitative
study. In details, 5 had been conducted in the United States,3,4,8,29,35
3 had been conducted in the United Kingdom,1,30,33 2 had been
conducted in Australia,28,37 1 had been conducted across Europe,2
and 1 each had been conducted in Ireland,35 Northern Ireland,32
Norway,36 and South Korea.31 The sample size varied widely
among the studies, from 4528 to 8953 nurses and from 181 to
78033 patients, for a total of 5400 participants (3649 nurses
and 903 patients). The studies included data collected using
forms adapted from previous surveys (11 studies1,3,4,8,28,31,33–37),
used a new questionnaire (3 studies2,29,32), or used a focus group
technique (1 study30). Most of those concerning nurses' priorities
(10 of 15 studies) involved professional associations, including the
US-based Oncology Nursing Society, the European Oncology
Nursing Society, the Korean Oncology Nursing Society, the
Norwegian Society of Nurses, and the United KingdomOncology
Nursing Society.
With respect to the nurse participants' qualifications and ex-
perience in oncology, there were large differences among the 13
studies that included nurses. Of the study participants, 1% to
23% held a doctoral degree, the highest nursing qualification,
whereas cancer nursing experience ranged from 1 to more than
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21 years. Only 3 of the studies involving nurses failed to report
these data about their participants.30,33,37
n Methodological Quality
When the 15 studies were evaluated for methodological qual-
ity with MMAT (Appendix 2), nearly all received a “yes” score
on both of the 2 screening questions, with the exception of
Moorcraft et al's33 study, which received only one. With re-
spect to methodological quality, the scores varied from 25%
(1 of 4 quality criteria met) to 100% (all criteria met). For
the 14 studies with a quantitative descriptive or Delphi design,
only one met all 4 methodological criteria,33 12 met 3 of the 4
criteria,1–4,8,28,29,31,32,35–37 and one met 1 of the 4 criteria.33
The single qualitative study30 had a score of 75%. As a whole, the
studies' methodological quality was considered sufficiently good.
Low scores were attributable to a response rate less than 60%
(10 studies), unreported response rate (2 studies), lack of informa-
tion about researchers' influence in qualitative research (1 study),
or concerns about the measurements' appropriateness or the sample's
representativeness in quantitative research (1 study).
The process of setting the health research priorities was evalu-
ated using Viergever et al's26 checklist and Appendix 3. The degree
to which the evaluation was complete varied from two to all items
assessed. In the context theme, the environment and the research
priorities' focus were detailed in all studies (100%). In 14 studies
(93.4%), the process of setting priorities was reported in detail,
and the participants involved in the studies always were described
(100%). The information and sources were reported in 12 studies
(80%). Plans to translate and implement the research priorities
were referenced in 7 (46.7%) and 9 (60%) studies, respectively.
All studies reported the way in which priorities were determined;
however, only 6 (40%) reported when, and the way in which,
the priorities established were evaluated. Finally, all studies de-
scribed the approach used well.
n Research Priorities
All 15 studies summarized the top research topics (mean, 10; range,
5-20). Nurses' 5 top research priorities are shown in Table 2. Nine
studies set research priorities for nurses' knowledge of symptom and
pain control, including in the palliative setting.1–4,8,28,31,35,37 The
symptoms of greatest concern in these studies were nausea and
vomiting3,37; constipation, mucositis, and nutrition37; and fatigue,
neuropathy, psychological distress, cognitive impairment, and de-
pression.3 With respect to education, information, and communi-
cation, the studies highlighted communication between nurses
and both physicians and patients,36 patients' educational needs,2,37
Figure 1 n Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram for selecting articles to include in the
mixed-method systematic review.
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communication issues for patients throughout the cancer jour-
ney,32,34 and the way to involve the patients in care decisions.28
Several studies highlighted patients' and families' quality of life
(QoL4,30,35) and medical care's effect on it.2,8 Quality of life is
a multidimensional concept that emphasizes personal feelings and
judgments, including their physical, psychological, social, interper-
sonal, and financial aspects.2,31,36 Issues about the professional di-
mension included interdisciplinary working and networking stress,
burnout, and coping2; improving retention and reducing turn-
over29; and health system issues.37
The 2 studies on patients' perspectives (Table 3) prioritized
cancer detection and prevention, including the development of
techniques to identify particular cancers easily and effectively
and identify cancer's risk factors and causes. These studies have
furthermore prioritized the need of a better scientific understand-
ing.30,33 They also revealed that patients want research on whether,
and the way in which, environmental factors (eg, air pollution, elec-
tricity pylons, mobile phones, TVs, computers, microwave ovens,
and aerosols), genetics, diet, anxiety and stress cause cancer.30,33
n Research Categories
From the analysis, nurses and patients' research priorities (only
top 5 considered) were grouped into 3 categories (Table 4): (1)
“disease control and management” (cancer prevention, early detec-
tion, management of treatments and symptoms, therapy adherence,
complementary and alternative therapies, late effects, participation
in making decisions to end of life, palliative care, and QoL/effect
on life), (2) “patient-related issues” (psychological/psychosocial
experiences, relational aspects, communication, and education),
and (3) “professional dimension and issues” (satisfaction, staffing,
turnover, stress, burnout, coping, cancer nursing research, health
system issues, access to and continuity of care, department
organization, cost-effectiveness).
n Discussion
This mixed-method systematic review identified both cancer
nurses' and patients' priorities for research through a comprehen-
sive assessment of the literature from 2000 to 2018. Contribu-
tions about research priorities came from the United States,
Australia, and various European countries. Nine of the 15 studies
included used a descriptive methodology, in which the study de-
sign used most commonly was a cross-sectional survey, followed
by the Delphi technique. According to Keeney et al,38 the most
appropriate method to investigate research priorities in this type
of research is a multistaged survey, the goal of which is to achieve
consensus on an issue, and 6 of the 15 studies included in this re-
view used such a survey.
In assessing the quality of the studies selected, several meth-
odological limitations were identified that suggested the need
for greater attention in planning future studies with more rigor-
ous methodologies. For example, 10 of these studies had re-
sponse rates less than 60%, and 2 did not report the response
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sample represented the population studied (inclusion and exclusion
criteria were not described) and themeasurements were appropriate.
The 14 quantitative studies largely were descriptive surveys andDel-
phi projects that did not use validated tools but, instead, used
tools adapted from previous studies without piloting them in ad-
vance. Similar survey questionnaires were moreover used, but the
items did not cover all possible research areas. Some priorities, there-
fore, may not have been considered, so these studies may not neces-
sarily represent all cancer nurses' or patients' views. Nearly all of the
articles included provided complete descriptions of the data collec-
tion methods (study design and instruments), yet most lacked im-
portant information, such as the study period, which makes it
difficult to evaluate the evolution of priorities over time. In qualita-
tive research, the researcher's role is influential at all stages, from the
formulation of the research question to data collection and analysis,
and interpretation of the findings.22 The qualitative study included
here30 did not provide information on their searchers' influence (eg,
whether nurses and researchers knew each other), and this lack of
information may represent a bias. To evaluate the process of setting
health research priorities, such features as context, use of a com-
prehensive approach, gathering information, planning for imple-
mentation, determining priorities and methods, evaluation, and
transparency also were evaluated.26 The results of these evalua-
tions showed distinct variability. Significant attention was paid to
the context (resources available; focus on priorities, values, and prin-
ciples considered; environment in which the priorities were investi-
gated), and the participants' engagement was notable in all studies,
suggesting the solidity of the methods and relevance of the topics
selected. Only 2 studies31,33 considered the economic and finan-
cial aspects, which suggests that future studies need to give these
factors more attention. The reduction in the availability of financial
resources for nursing research or for health professionals in general
is a problem felt acutely, which translates to limited approval of re-
source requests or failure to allocate resources for research.
Nursing research priorities have been studied in theUnited States
and Canada for many years, where studies have been conducted since
the late 1980s.39–42 Today, studies on nursing research priorities
continue to attract considerable interest because many research
areas are complex, subject to frequent changes and updates, and require
sustained focus and effort. Several nursing societies have surveyed
their members for the past 30 years. For example, the Oncology
Nursing Society, founded in 1975, has conducted this type of survey
in the United States approximately every 4 years since 1980.3 Other
associations have conducted surveys in European countries1,2,32,36
and in Australia37 and South Korea.31 The Asian Oncology Nursing
Society is relatively young and represents 9 Asian countries' oncology
nursing societies; it includes the Korean Oncology Nursing Society,
which conducted a membership survey in 2003, whereas the first
Asian conference was held in Thailand in 2013.43 Although these
organizations are important, only members' opinions are considered
in their surveys, which could limit the identification of nursing
research priorities.
In several of the articles included in this review, research prior-
ities were ranked in order of importance (eg, Cox et al,1 Berger
et al,4 Barrett et al,28 Cohen et al29). The priorities, however, were
illustrated with examples only in 4 articles: 2 studies described in
detail talking about symptoms,2,30 whereas the difference between
“QoL” and “effect on life” was explained to participating patients
only in 2 surveys.3,37
We categorized nurses and patients' research priorities into 3
main research fields. The first, “disease control and management,”
refers to medical interventions' delivery (eg, prevention and risk re-
duction, screening, treatment, survivorship, and end-of-life care)
and is similar to the cancer care continuum Charalambous and
colleagues44 described. This field includes symptommanagement,
disease trajectory, prevention and risk reduction, late treatment ef-
fects, early presentation of cancer symptoms and early diagnosis,
and uncertainty after cancer treatment. We believe that most nurses
gave high priority to this area because of interventions' great com-
plexity and frequent clinical use to manage and prevent symptoms.
Symptom management, such as acute and chronic pain, or pain
management in general, was always present in the studies from
2000 to 2018 (10 of 15 studies), unlike QoL/effect on life, which
has not been considered often in the past 10 years (present in 6 of
15), perhaps because it is assessed indirectly already and is no longer
a priority. All of these aspects were important to both nurses and
patients. Symptom burden represents a significant problem be-
cause of the very complex therapies, and many interventions still
fail to be effective, as Coolbrandt and colleagues45 demonstrated.
Recent studies have focused on CHEMO-SUPPORT as nursing
interventions to reduce symptoms during chemotherapy.46 From
the patients' point of view, the care concept in the 2 studies consid-
ered includes cancer's effect on life/QoL, early cancer detection and
prevention, risk factors and causes, and treatment and research.30,33
Patients also were concerned about environmental risks, hereditary
factors, and carcinogenesis. Patients in 1 study also indicated that
they wanted to know more about cancer science's development.30
“Patient-related issues” is another research field important to
nurses and includes psychological, behavioral, relational, and
communication factors, all of which are patients' information needs
that often are problematic for them to obtain. In particular, educa-
tion and information fields were considered as research priorities
Table 3 • Patients' Top 5 Research Priorities
Reference First Priority Second Priority Third Priority Fourth Priority Fifth Priority
Corner et al,30
2007
Effect on life, how to live with
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very often during the period this study investigated (present in 8
of 15 studies). Nursing research investigates these kinds of prob-
lems rarely, and they continue to remain a priority. According to
Charalambous et al,44 the main field nurses have investigated is
“teaching, counseling, and guidance,” which includes activities
to encourage and promote cancer patients' self-care and coping.
Nursing research also should include investigations of forms of
psychological support to promote patients' well-being.
A third research field important to nurses is the “professional
dimension and issues,” which includes the nurse as a professional
figure and his or her position in health services. The nurse as a
professional figure includes one in cancer nursing education and
research, interdisciplinary work and networking, skills and compe-
tencies, stress, burnout, coping, job satisfaction, participation in
making decisions, and departmental organization. The nurses' role
in health services includes the range of positions and responsibili-
ties that cancer nurses have developed to support people who live
with cancer or are at risk of cancer.44 Research on the nurses' po-
sition in health services seems to bemissing in part from the cancer
research agenda.47,48 Considering that nurses play a crucial role in
oncology care, further studies are needed urgently. These priorities
were seen infrequently in the studies described here, unlike the is-
sues related to patients' priorities. It seems that nurses' attention
has focused primarily on addressing priorities that respond to the
patients' needs (the disease itself or their nursing problems) with
respect to the professional dimension or the context of care.
Among the studies analyzed, Cox and colleagues'1 study is novel
among the surveys of cancer priorities because they investigated
nursing research priorities from both the nurses' and patients' points
of view. Their Delphi survey, however, led patients to respond by
thinking about nursing activities rather than their own problems
or needs. For this reason, we excluded the article from the analysis
in the section of this study that reports patients' point of view.
Except for this example, oncology nurses generally have not collab-
orated with patients, although such collaborations exist in other pro-
fessional groups (eg, physiotherapists and osteopaths). The main
factor to be considered for future clinical studies remains patients'
primary role in research; thus, cancer researchers and clinicians must
consider their needs and perspectives.33
It may be useful to develop qualitative studies and involve pa-
tients in focus or discussion groups to share the results of the lit-
erature and establish with them the main priorities. This may be
conducted, for example, by asking patients what do they expect
from nurses through perception studies (these studies can be very
inspirational) and by planning future investigations/surveys with
other health professionals (ie, doctors, psychologists).
This review has some limitations. First, only primary studies
were included, and thus, any studies reported in the gray literature
were not considered because they are not formally published.
Second, no studies were found that were conducted in lower in-
come countries, although cancer risk factors and mortality have
been reported in these regions.6 Thus, the research priorities of
patients and nurses from these countries are unknown. This is
unfortunate, as it would be useful to understand the different
perspectives of these cancer patients and the nurses who care for
them, as well as other treatment and nursing issues in conditions
of severe economic hardship, such as poor access to cancer or pain
drugs, or care facilities. Third, we searched with English terms and
included articles written only in English from 2000 to 2018, which
may have caused selection bias. Fourth, we excluded patients with
hematological cancer or those undergoing bonemarrow transplan-
tation. Fifth, to ensure that we investigated nurses and patients'
specific points of view, we excluded studies in which nurses reported
their perceptions of patients' interests, or the converse. As a conse-
quence, 2 studies were omitted and the results of one were considered
only in part.
n Conclusions
Many oncology nursing societies and organizations have explored
the priorities in oncology nursing and have provided important
suggestions to researchers.
During the years, certain priorities always have been included
among the top 5 (symptommanagement or communication, ed-
ucation, and information fields), in contrast to others that have
not been reported in recent years (QoL/effect on life) or those
identified recently (early detection of cancer).
Despite the increasing emphasis on the need to include pa-
tients when establishing research priorities that inform cancer
care, we found few studies that did so. Researchers and oncology
nursing societies are the stakeholders better represented, but pri-
ority topics for future research also should include patients and
their advocacy organizations. The integration of nurses and pa-
tients' priorities for research would be a starting point to develop
a new research priority agenda that can be adapted locally accord-
ing to each context. To do so, it would be useful not to limit one-
self to simple lists of priorities but to explore further from a
qualitative point of view what these priorities mean for patients
and nurses. In addition, greater collaboration with other profes-
sionals is desirable in such issues as psychological support or
counseling. Greater attention to nurses' role and their leadership
also is necessary, given the increasing complexity of cancer care in
which nurses have a clear central position. A reflection on their
educational needs and on developing competence in the cancer
nursing research field is also necessary. Finally, understanding
the way the development of nursing research leadership and a
clinical cancer nursing specialization influences patients' outcomes,
as well as the cost and its relation to efficacy in cancer nursing,
should become a priority.
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cancer nursing, oncology patient, research priorities
(cancer nursing OR oncology patient) AND research priorities
CINAHL “cancer patients” AND “issues” ANDunresolvedOR “cancer patients” AND “needs” ANDpriorities OR (MH “Health
Services Needs and Demand+”) AND (MH “Needs Assessment”) AND “unmet needs” AND AFT2000
(“cancer priorities”OR “research priorities”) AND (User OR healthcare users OR oncology patient OR cancer patient
OR oncology user OR cancer consumers) AND research priorities ((“research priorities”[All Fields] OR “health
priorities”[All Fields]) AND “cancer patients”[All Fields]) OR ((“patients perspective”[All Fields] OR “patients
perspectives”[All Fields] OR Patient Participation/methods) AND (“Needs Assessment”[MeSH] OR “Health Services
Needs and Demand”[MeSH] OR needs[ti] OR priorities[ti])) AND (“Patients”[MeSH] OR patients[ti] OR patient
[ti]) AND ((“Neoplasms”[MeSH] OR cancer[tiab] OR oncology[tiab]) OR (priorities[ti] AND “cancer patients”[All
Fields])) OR (survivors[ti] AND cancer[ti] AND needs[ti]) AND (“2000/01/01”[PDAT]: “3000/12/31”[PDAT])
NOT (palliative[All Fields] OR (“pediatrics”[MeSH Terms] OR “pediatrics”[All Fields] OR “pediatric”[All Fields]))
NOT (“pediatrics”[MeSH Terms] OR “pediatrics”[All Fields] OR “paediatric”[All Fields] OR child*)
MEDLINE ((((((“research priorities” AND (neoplasms[MeSH] OR cancer) NOT (children OR child OR paediatric OR pediatric))
AND jsubsetn[text])) OR (((“research priorities”[All Fields] OR “nursing research priorities”[All Fields] OR (“nursing
methodology research”[MeSH Terms] AND priorit*[tiab] AND cancer[tiab])) AND (“cancer nursing”[All Fields] OR
“Oncology Nursing”[MeSH] OR ((“nursing”[MeSH Terms] OR “Oncology nurses”[tiab]) AND “neoplasms”[MeSH
Major Topic]) OR (nursing[tiab] AND cancer[tiab]) OR “neoplasms/nursing”[MeSH Terms])) OR (“Oncology
Nursing”[MeSH] AND “Health Priorities”[MeSH] AND “Research”[MeSH]) NOT (“pediatric nursing”[MeSH
Terms] OR pediatric[tiab]))))) OR ((((“unresolved problem” OR “unresolved problems”)) OR unmet needs[MeSH]
AND (nursing research[MeSH] OR research/nu[sh] OR “nursing research”[tiab] OR (research[tiab] AND nurses[tiab])
OR (research[tiab] AND “oncology nursing”)) AND (neoplasms[MeSH] OR cancer[tiab])) NOT(pediatric OR
paediatric OR child* OR palliative)) AND (research[ti] OR research[MeSH]) AND (nurs*[ti] OR nurs*[MeSH])




(“oncology nursing” AND (research OR priorit*)) NOT pediatric
(“cancer patients” OR “cancer survivors”) AND (“unmet needs” OR unresolved OR priorit*) NOT pediatric
(TITLE-ABS-KEY (*cancer patients) AND TITLE-ABS-KEY (unmet needs)) AND TITLE-ABS-KEY (patient
perspective*)
Scopus ((TITLE-ABS-KEY (“oncologic nursing” AND research AND priorit*)) AND ((nurs)) AND (research priorit*) AND
PUBYEAR >2000) AND NOT child* AND NOT palliative
TDNet (oncologic nursing) AND priority* ANDNOT pediatric ANDNOT pediatric AND NOT palliative ANDNOT child*
Abbreviations: CINAHL, Cumulative Index toNursing and AlliedHealth; PROSPERO, International Prospective Register of Systematic Reviews–Centre for Review and
Dissemination University of York; TDNet, TDNet's basic discovery portal service.
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Appendix 2 • Quality Evaluation of the 15 Studies Included in the Review Using MMAT, the Mixed Method








Screening questions Are there clear qualitative and quantitative research
questions or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 56% response rate
Berger et al,4
2005
Screening questions Are there clear qualitative and quantitative research
questions or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 15% response rate
Browne et al,2
2002
Screening questions Are there clear qualitative and quantitative research
questions or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 30%-33% response rate
Cohen et al,29
2004
Screening questions Are there clear qualitative and quantitative research
questions or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 54% response rate
Corner et al,30
2007
Screening questions Are there clear qualitative and quantitative research
questions, or a clear mixed methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Qualitative Are the sources of qualitative data (archives, documents,
informants, observations) relevant to address the research
question (objective)?
*
Is the process for analyzing qualitative data relevant to
address the research question (objective)?
*
Is appropriate consideration given to how findings relate to the
context, eg, the setting, in which the data were collected?
*
Is appropriate consideration given to how findings relate
to researchers' influence, eg, through their interactions
with participants?
* There is no information
about the influence of
researchers.
(continues)
Priorities for Cancer Research Cancer NursingW, Vol. 43, No. 3, 2020▪251
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Appendix 2 • Quality Evaluation of the 15 Studies Included in the Review Using MMAT, the Mixed Method








Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? *
Doorenbos
et al,8 2008
Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 12% response rate
Lee et al,31
2003
Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *




Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *




Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 54% response rate
Moorcraft
et al,33 2016
Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
* The study aim is stated
only in the abstract.
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? * Data are not reported.
Are measurements appropriate? * Data are not reported.
Is there an acceptable response rate (60% or above)? * Data are not reported.
(continues)
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Appendix 2. • Quality Evaluation of the 15 Studies Included in the Review Using MMAT, the Mixed Method









Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? *
Ropka et al,35
2002
Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *




Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 43%–54% response rate
Yates et al,37
2002
Screening questions Are there clear qualitative and quantitative research questions
or a clear mixed-methods question?
*
Do the collected data allow one to address the research
question (objective)?
*
Quantitative descriptive Is the sampling strategy relevant to address the quantitative
research question?
*
Is the sample representative of the population under study? *
Are measurements appropriate? *
Is there an acceptable response rate (60% or above)? * 54.2% response rate
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